Interesting point. That would imply they would be paying several times more for it by paying the middle man. It would also mean that they would not have exclusivity for their market. As Genea has an exclusive agreement for their own market, they have an incentive to deal directly with BCT. But we won't know that till they make an order. Right now Labcon is moving fast so they may be able to ramp up sales faster than other OEMs.. so between getting a larger order from Labcon or a first order from Genea.. I'm happy to see more vols going to Labcon. The risk for everyone (customers I mean) is that BCT is acquired by an OEM like Labcon. That means the technology is exclusive to them and they would have more leverage to charge higher prices from eager buyers - more leverage than BCT has given their position in the chain.
- Forums
- ASX - By Stock
- BCT
- Ann: Labcon begins production of Bluechiip-enabled consumables
Ann: Labcon begins production of Bluechiip-enabled consumables, page-16
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.728M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1759058 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 2824274 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1759058 | 0.003 |
9 | 3824333 | 0.002 |
5 | 6800000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 2824274 | 4 |
0.005 | 2620572 | 5 |
0.006 | 2321045 | 5 |
0.007 | 630570 | 3 |
0.008 | 135714 | 1 |
Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online